Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 6.15
-0.12 (-1.91%)
At close: Mar 19, 2026
SHA:688373 Revenue
In the year 2025, Shanghai MicuRx Pharmaceutical had annual revenue of 141.77M CNY with 8.83% growth. Shanghai MicuRx Pharmaceutical had revenue of 37.79M in the quarter ending December 31, 2025, with 15.52% growth.
Revenue
141.77M
Revenue Growth
+8.83%
P/S Ratio
27.91
Revenue / Employee
754.11K
Employees
177
Market Cap
3.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 141.77M | 11.50M | 8.83% |
| Dec 31, 2024 | 130.27M | 39.50M | 43.51% |
| Dec 31, 2023 | 90.78M | 42.57M | 88.31% |
| Dec 31, 2022 | 48.21M | 40.55M | 529.33% |
| Dec 31, 2021 | 7.66M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.39B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| Huaren Pharmaceutical | 1.26B |
| Harbin Medisan Pharmaceutical | 874.60M |
| Shandong Wohua Pharmaceutical | 816.95M |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Tibet AIM Pharm. | 628.02M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |